Literature DB >> 31900106

Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.

Ekerette Friday Ekere1, Monday F Useh2, Henshaw Uchechi Okoroiwu3, Tatfeng Youtchou Mirabeau4.   

Abstract

BACKGROUND: Cysteine-cysteine chemokine receptor 5 is the main HIV co-receptor involved in the virus and cell-to-cell spread. A variant of the CCR5 gene known as CCR5-Δ32 which is a product of 32 base pair deletion in the gene plays critical role in the infection and progression to AIDS. The study was carried out to determine the CCR5 genotype of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar.
METHODS: A total of 100 subjects attending HIV clinic, University of Calabar Teaching Hospital were purposively recruited for this study. DNA was extracted from each sample using the Quick gDNA miniprep DNA extraction kit, Zymo Research. Polymerase chain reaction (PCR) was used in the amplification of CCR5 gene in each DNA in a 9700 ABI Thermo cycler and then resolved on 4% agarose gel electrophoresis. RESULT: Out of the 100 samples assessed, 100 (100%) were homozygous for the CCR5 wild type gene (CCR5-wt), while none (0%) was homozygous for the CCR5-Δ32 (mutant type), and heterozygosity was not observed.
CONCLUSION: This study observed absence of CCR5-Δ32 deletion gene among the studied subjects in Calabar, implying lack of genetic advantage in HIV infection and possible rapid progression towards AIDS if other precautions are not checked.

Entities:  

Keywords:  CCR5; CCR5 genotype; CCR5-Δ32; HIV; Mutant CCR5; Wild type CCR5

Mesh:

Substances:

Year:  2020        PMID: 31900106      PMCID: PMC6942402          DOI: 10.1186/s12879-019-4737-1

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  26 in total

Review 1.  The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.

Authors:  Alison P Galvani; John Novembre
Journal:  Microbes Infect       Date:  2005-01-08       Impact factor: 2.700

2.  Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.

Authors:  Abdel-Halim Salem; Mark A Batzer
Journal:  Mutat Res       Date:  2006-12-12       Impact factor: 2.433

3.  Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

Authors:  R Liu; W A Paxton; S Choe; D Ceradini; S R Martin; R Horuk; M E MacDonald; H Stuhlmann; R A Koup; N R Landau
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

4.  Global distribution of the CCR5 gene 32-basepair deletion.

Authors:  J J Martinson; N H Chapman; D C Rees; Y T Liu; J B Clegg
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

Review 5.  New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.

Authors:  Hossein Khorramdelazad; Vahid Bagheri; Gholamhossein Hassanshahi; Masoud Zeinali; Alireza Vakilian
Journal:  J Neuroimmunol       Date:  2015-11-24       Impact factor: 3.478

6.  Marked differences in CCR5 expression and activation levels in two South African populations.

Authors:  Anabela C P Picton; Sharon Shalekoff; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 7.  Patterns of ethnic diversity among the genes that influence AIDS.

Authors:  Cheryl Winkler; Ping An; Stephen J O'Brien
Journal:  Hum Mol Genet       Date:  2004-02-05       Impact factor: 6.150

8.  Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers.

Authors:  Ute V Solloch; Kathrin Lang; Vinzenz Lange; Irina Böhme; Alexander H Schmidt; Jürgen Sauter
Journal:  Hum Immunol       Date:  2017-10-05       Impact factor: 2.850

Review 9.  Human genes that limit AIDS.

Authors:  Stephen J O'Brien; George W Nelson
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

10.  CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Authors:  L Wu; W A Paxton; N Kassam; N Ruffing; J B Rottman; N Sullivan; H Choe; J Sodroski; W Newman; R A Koup; C R Mackay
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

View more
  4 in total

1.  Prevalence of asymptomatic malaria in HIV-infected subjects on cotrimoxazole antimalarial prophylaxis attending a tertiary health care center in southern Nigeria: a cross-sectional study.

Authors:  Ekerette Friday Ekere; Tatfeng Youtchou Mirabeau; Henshaw Uchechi Okoroiwu
Journal:  Germs       Date:  2020-03-02

2.  COVID-19 in WHO African Region: Account and Correlation of Epidemiological Indices with Some Selected Health-related Metrics.

Authors:  Henshaw Uchechi Okoroiwu; Christopher Ogar Ogar; Dennis Akongfe Abunimye; Ifeyinwa Maryann Okafor; Ikenna Kingsley Uchendu
Journal:  Ethiop J Health Sci       Date:  2021-11

3.  CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.

Authors:  Basil Chukwuebuka Ndikom; Mahmut Cerkez Ergoren; Murat Sayan; Gamze Mocan; Umut Fahrioğlu
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

4.  Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.

Authors:  Ifeyinwa M Okafor; Solomon O Ugwu; Henshaw U Okoroiwu
Journal:  BMC Gastroenterol       Date:  2020-10-30       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.